These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2658822

  • 21. [Prognosis in ovarian cancer as a function of the results of the second-look laparatomy].
    Varette C, de Gramont A, Louvet C, Gonzalez-Canali G, Krulik M, Drolet Y, Pigné A, Marpeau L, Barrat J, Gallot D.
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):222-7. PubMed ID: 2723353
    [Abstract] [Full Text] [Related]

  • 22. [Expectations and defeat in the treatment of epithelial cancer of the ovary].
    Weil M, Borel C, Auclerc G, Forget G, Durandin-Truffinet M, Thill L, Khayat D, Jacquillat C.
    Ann Med Interne (Paris); 1990; 141(1):15-9. PubMed ID: 2321883
    [Abstract] [Full Text] [Related]

  • 23. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 24. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE.
    Gynecol Oncol; 1994 Dec 15; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [Abstract] [Full Text] [Related]

  • 25. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
    Tournigand C, Louvet C, Molitor JL, Dehni N, Lejeune V, Sezeur A, Pigne A, Marpeau L, Cady J, de Gramont A.
    Gynecol Oncol; 2001 Nov 15; 83(2):198-204. PubMed ID: 11606072
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of advanced ovarian cancer].
    de Gramont A, Krulik M, Pigne A, Brissaud P, Sirinelli A, Hubert D, Zylberait D, Debray J.
    Sem Hop; 1984 Mar 29; 60(14):957-60. PubMed ID: 6326283
    [Abstract] [Full Text] [Related]

  • 27. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Mar 29; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 28. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 Mar 29; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 29. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG, Gershenson DM, Malpica A, Deavers M.
    Am J Surg Pathol; 2006 Nov 29; 30(11):1367-71. PubMed ID: 17063075
    [Abstract] [Full Text] [Related]

  • 30. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer].
    Sawada M, Ozaki M, Inagaki M, Hongo J, Hirota Y, Takayama K, Arimoto Y, Wada T, Taki I, Yanagita T.
    Gan To Kagaku Ryoho; 1987 Dec 29; 14(12):3301-4. PubMed ID: 3120644
    [Abstract] [Full Text] [Related]

  • 31. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
    Inagaki J, Ogawa M, Horikoshi N, Ezaki K, Inoue K, Aiba K, Komyo M, Miyamoto H, Ikeda K, Kubo H.
    Gan No Rinsho; 1983 Aug 29; 29(10):1291-5. PubMed ID: 6685195
    [Abstract] [Full Text] [Related]

  • 32. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY.
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar 29; 25(2):77-9, 123. PubMed ID: 2364794
    [Abstract] [Full Text] [Related]

  • 33. [Advances in the comprehensive treatment of ovarian cancer].
    Yakushiji M, Sugiyama T.
    Gan To Kagaku Ryoho; 1988 Jun 29; 15(6):1855-62. PubMed ID: 2454614
    [Abstract] [Full Text] [Related]

  • 34. [Therapeutic results of malignant ovarian tumor].
    Fukazawa I, Masubuchi S, Okajima H, Fukuda K, Hayashi K, Yokosuka K, Miyata R, Masubuchi K.
    Gan No Rinsho; 1984 Jun 29; 30(7):819-26. PubMed ID: 6431145
    [Abstract] [Full Text] [Related]

  • 35. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY, Zhang R, Huang MN, Li N, Wang GX, Liu LY.
    Ai Zheng; 2003 Apr 29; 22(4):424-7. PubMed ID: 12704005
    [Abstract] [Full Text] [Related]

  • 36. Advances in the management of epithelial ovarian cancer.
    Berkenblit A, Cannistra SA.
    J Reprod Med; 2005 Jun 29; 50(6):426-38. PubMed ID: 16050567
    [Abstract] [Full Text] [Related]

  • 37. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC.
    Am J Obstet Gynecol; 2000 Jun 29; 182(6):1321-7. PubMed ID: 10871445
    [Abstract] [Full Text] [Related]

  • 38. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
    Ojeda B, Llanos M, Brunet J, Lacasta A, Alonso MC, Rueda A, Delgado E, Badía J, López López JJ.
    Med Clin (Barc); 1995 Feb 11; 104(5):165-9. PubMed ID: 7877374
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of 63 advanced ovarian carcinomas].
    Liu LY, Hong WJ, Hou YJ, Yao ZH, Wu AR, Li L.
    Zhonghua Zhong Liu Za Zhi; 1987 Sep 11; 9(5):375-8. PubMed ID: 3452529
    [Abstract] [Full Text] [Related]

  • 40. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.
    Bone Marrow Transplant; 2000 Jul 11; 26(1):61-7. PubMed ID: 10918406
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.